Clinical Trials Directory

Trials / Completed

CompletedNCT01861600

Stool Composition and Stool Characteristics in Healthy Term Infants Fed Human Milk or Infant Formulas

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
375 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
7 Days – 14 Days
Healthy volunteers
Accepted

Summary

The primary efficacy objective was to determine and compare stool composition (stool soap and non-soap fatty acids, total fatty acids, minerals, and other stool constituents) among the feeding groups.

Detailed description

The purpose of this study is to evaluate the effects of term infant formula containing high 2-palmitic vegetable oil on stool composition and characteristics and to investigate the effect of both high 2-palmitic vegetable oil and oligofructose in infant formula on stool softness and bacteria. Because some studies demonstrate the benefit of high concentrations of a non-digestible carbohydrate in the formula, we will study 2 concentrations of added oligofructose.

Conditions

Interventions

TypeNameDescription
OTHERS-26 Gold(13.4 g/L protein) with 100% Fat Blend A
OTHERS-26 Gold EF1(13.4 g/L protein) with 60% Fat Blend A and 40% Betapol fat blend
OTHERS-26 Gold EF2(13.4 g/L protein) with 60% Fat Blend A and 40% Betapol fat blend, and supplemented with 3.0 g/L oligofructose
OTHERS-26 Gold EF3(13.4 g/L protein) with 60% Fat Blend A and 40% Betapol fat blend, and supplemented with 5.0 g/L oligofructose
OTHERHuman MilkHuman Milk

Timeline

Start date
2009-04-01
Primary completion
2009-08-01
Completion
2009-08-01
First posted
2013-05-23
Last updated
2013-05-23

Locations

1 site across 1 country: Philippines

Source: ClinicalTrials.gov record NCT01861600. Inclusion in this directory is not an endorsement.